HMG-CoA Reductase Inhibitors
. Ed(s): Schmitz, G.; Torzewski, M.
ISBN 10: 376436307X ISBN 13: 9783764363079
Verlag: Birkhauser Verlag AG, 2002
Neu
Hardcover
Verkäufer
Kennys Bookstore, Olney, MD, USA
Verkäuferbewertung 5 von 5 Sternen
AbeBooks-Verkäufer seit 9. Oktober 2009
Dieser Artikel ist nicht mehr verfügbar.
Beschreibung
Beschreibung:
HMG-CoA reductase inhibitors (statins) are established drugs for the treatment of hypercholesterolemia. This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and its sequelae. It emphasises on the scientific background to the discoveries and the development of the therapy. Editor(s): Schmitz, G.; Torzewski, M. Series: Milestones in Drug Therapy. Num Pages: 161 pages, biography. BIC Classification: MJD; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 235 x 155. Weight in Grams: 580. . 2002. Hardback. . . . . Books ship from the US and Ireland. Bestandsnummer des Verkäufers V9783764363079
Inhaltsangabe:
List of contributors. Preface. Stefano Bellosta, Rodolpho Paoletti, Alberto Corsini: History and development of HMG-CoA reductase inhibitors. Margaret E. Brousseau and Ernst J. Schäfer: Structure and mechanisms of action of HMG-CoA reductase inhibitors. Jörg Kotzka, Wilhelm Krone and Dirk Müller-Wieland: Sterol-regulatory element binding proteins (SREBPs): gene regulatory target of statin action. Gerd Schmitz and Michael Torzewski: Cellular effects of HMG-CoA reductase inhibitors on blood cells (monocytes, macrophages, platelets). Koichi Node and James K. Liao: Effects of HMG-CoA reductase inhibitors on cells of the vascular wall - pleiotropic effects of HMG-CoA reductase inhibitors. Hans-Peter Thomas and Elisabeth Steinhagen-Thiessen: Indications and contraindications for statin treatment (primary and secondary prevention of hypercholesterolemia). Helena K. Gylling and Tatu A. Miettinen: Clinical experience: studies with HMG-CoA reductase inhibitors. C. Berry, A. Davie and J. McMurray: Cost-effectiveness of statins in primary and secondary prevention of coronary heart disease. Index
Reseña del editor: HMG-CoA reductase inhibitors (statins) are established drugs for the treatment of hypercholesterolemia. Furthermore, they induce regression of vascular atherosclerosis as well as reduction of cardiovascular-related morbidity and death in patients with and without coronary artery disease. This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and its sequelae. Emphasis is placed on the scientific background to the discoveries and the development of the therapy, including an overview of the current state of knowledge of the drugs. Clinical data are reviewed extensively. This book not only provides the reader with valuable information but also stimulates further research into the pathogenesis of atherosclerosis and the mechanisms behind the action of effective statins. It sets the stage for creative thinking among scientists of many disciplines for the accomplishment of our ultimate goals in treating atherosclerosis and its sequelae. This topical volume...
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Bibliografische Details
Titel: HMG-CoA Reductase Inhibitors
Verlag: Birkhauser Verlag AG
Erscheinungsdatum: 2002
Einband: Hardcover
Zustand: New
Beste Suchergebnisse beim ZVAB
Beispielbild für diese ISBN
HMG-CoA Reductase Inhibitors.
Anbieter: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Deutschland
Verkäuferbewertung 5 von 5 Sternen
2002. 16 x 24 cm. X, 151 S. X, 151 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. (Milestones in Drug Therapy). Sprache: Englisch. Artikel-Nr. 378ZB
Gebraucht kaufen
EUR 24,00
Versand:
EUR 30,00
Von Deutschland nach USA
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
HMG-CoA Reductase Inhibitors
Anbieter: Buchpark, Trebbin, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher. Artikel-Nr. 400306/2
Gebraucht kaufen
EUR 87,05
Versand:
EUR 105,00
Von Deutschland nach USA
Anzahl: 1 verfügbar
Foto des Verkäufers
HMG-CoA Reductase Inhibitors
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - HMG-CoA reductase inhibitors (statins) are established drugs for the treatment of hypercholesterolemia. Furthermore, they induce regression of vascular atherosclerosis as well as reduction of cardiovascular-related morbidity and death in patients with and without coronary artery disease. This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and its sequelae. Emphasis is placed on the scientific background to the discoveries and the development of the therapy, including an overview of the current state of knowledge of the drugs. Clinical data are reviewed extensively. This book not only provides the reader with valuable information but also stimulates further research into the pathogenesis of atherosclerosis and the mechanisms behind the action of effective statins. It sets the stage for creative thinking among scientists of many disciplines for the accomplishment of our ultimate goals in treating atherosclerosis and its sequelae. This topical volume. Artikel-Nr. 9783764363079
Neu kaufen
EUR 169,99
Versand:
EUR 62,09
Von Deutschland nach USA
Anzahl: 1 verfügbar
Foto des Verkäufers
HMG-CoA Reductase Inhibitors
Verlag:
Birkhäuser Basel, Birkhäuser Basel Okt 2002, 2002
ISBN 10: 376436307X
ISBN 13: 9783764363079
Neu
Hardcover
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. Neuware -HMG-CoA reductase inhibitors (statins) are established drugs for thetreatment of hypercholesterolemia. Furthermore, they induce regressionof vascular atherosclerosis as well as reduction ofcardiovascular-related morbidity and death in patients with and withoutcoronary artery disease. This book deals with statins which havesubstantially altered the approach to therapy of atherosclerosis and itssequelae. Emphasis is placed on the scientific background to thediscoveries and the development of the therapy, including an overview ofthe current state of knowledge of the drugs. Clinical data are reviewedextensively. This book not only provides the reader with valuableinformation but also stimulates further research into the pathogenesisof atherosclerosis and the mechanisms behind the action of effectivestatins. It sets the stage for creative thinking among scientists ofmany disciplines for the accomplishment of our ultimate goals intreating atherosclerosis and its sequelae. This topical volume.Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 164 pp. Englisch. Artikel-Nr. 9783764363079
Neu kaufen
EUR 169,99
Versand:
EUR 60,00
Von Deutschland nach USA
Anzahl: 2 verfügbar